BIOMAT Database Logo BIOMAT Database Logo

Photodynamic therapy: Part II. 1995

T J Dougherty
Department of Radiation Biology and Photodynamic Therapy, Roswell Park Cancer Institute, Buffalo, New York, USA.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017324 Hematoporphyrin Derivative A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors (HEMATOPORPHYRIN PHOTORADIATION). A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER. Hematoporphyrin D,Hematoporphyrin YHPD,Photofrin I,WR-246310,YHPD, Hematoporphyrin

Related Publications

T J Dougherty
[Potential and limitations of fluorescence diagnosis and photodynamic therapy. Part II: Photodynamic therapy].
February 2004, HNO,
T J Dougherty
Photodynamic therapy of cerebral glioma - a review. Part II - clinical studies.
August 2006, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
T J Dougherty
[Antimicrobial photodynamic therapy in dermatology. Part II: Viral and parasitic infections; perspectives].
January 2016, Annales de dermatologie et de venereologie,
T J Dougherty
Photodynamic Inactivation of plant pathogens part II: fungi.
February 2022, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology,
T J Dougherty
Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy.
August 2010, Journal of the American Academy of Dermatology,
T J Dougherty
Photodynamic therapy: update 2006. Part 2: Clinical results.
April 2007, Journal of the European Academy of Dermatology and Venereology : JEADV,
T J Dougherty
Antiplatelet therapy--Part II.
May 1993, The Western journal of medicine,
T J Dougherty
Heparin therapy - Part II.
January 1977, Cardio-vascular nursing,
T J Dougherty
[Eczema. Part II. Therapy].
February 1954, Rassegna internazionale di clinica e terapia,
T J Dougherty
Gene Therapy (Part II).
January 2020, Current gene therapy,
Copied contents to your clipboard!